Clinical Study of NovoClasp for Treating Moderate to Severe and Severe Degenerative Mitral Regurgitation
Clinical Study of NovoClasp for Treating Moderate to Severe and Severe Degenerative Mitral Regurgitation
Active, not recruiting · NCT06021509 · Registry updated 2023-09-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of NovoClasp for Treating Moderate to Severe and Severe Degenerative Mitral Regurgitation | Degenerative Mitral Valve Disease | Active, not recruiting | Not applicable | 2023-09-01 | NCT06021509 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Enlight Medical Technologies (Shanghai) Co., Ltd | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Anzhen Hospital, Capital Medical University | Beijing | China | 20 |